Publisher
Springer Science and Business Media LLC
Reference93 articles.
1. Geng X, Zhao Q, Yuan H, Li HL, Guo CY, Yang T, et al. The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fluoroscopic gastrostomy. BMC Gastroenterol. 2024;24(1):14.
2. Mohapatra S, Al Ghamdi SS, Charilaou P, Lopimpisuth C, Das A, Ngamruengphong S. Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Surveillance, Epidemiology, and End Results database. Gastrointest Endosc. 2024;9:S0016–5107(24)03190–0.
3. Li M, Shao D, Fan Z, Qin J, Xu J, Huang Q, et al. Non-invasive early detection on esophageal squamous cell carcinoma and precancerous lesions by microbial biomarkers combining epidemiological factors in China. J Gastroenterol. 2024;59(7):531–42.
4. Chandar AK, Keerthy K, Gupta R, Grady WM, Canto MI, Shaheen NJ, et al. Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study. Am J Gastroenterol. 2024;119(5):823–9.
5. Liu CQ, Ma YL, Qin Q, Wang PH, Luo Y, Xu PF, et al. Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thorac Cancer. 2023;14(1):3–11.